Latest Cancer: Skin news
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
posted June 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Second Primary Malignancy Risk Increased After Cutaneous B-Cell Lymphoma
posted April 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk for Subsequent Facial Keratinocyte Carcinoma Lower With Laser Treatment
posted January 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Laser Interstitial Thermal Therapy Beneficial for Brain Tumors 
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
1 in 3 Women and 1 in 4 Men Engage in Intentional Outdoor Tanning 
Melanoma Incidence and Deaths Disproportionately Impact Men 
Deep Learning Ensemble Shows Potential for Identifying Melanoma 
Study Explores the Etiology of Melanoma Associated With Tanning Bed Usage 
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma 
Skin Cancer Risk Reduced for Patients Treated With Nicotinamide Monthly Specialist Briefings
Stay Connected
